Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1204056923
rs1204056923
TTN ; TTN-AS1
0.700 GeneticVariation UNIPROT

dbSNP: rs1238066548
rs1238066548
MAP4K1 ; LOC105372397
0.700 GeneticVariation UNIPROT

dbSNP: rs1277219458
rs1277219458
PASK
0.700 GeneticVariation UNIPROT

dbSNP: rs1451501407
rs1451501407
GUCY2D
0.700 GeneticVariation UNIPROT

dbSNP: rs1458591077
rs1458591077
TTN ; TTN-AS1
0.700 GeneticVariation UNIPROT

dbSNP: rs1484691555
rs1484691555
PAK5
0.700 GeneticVariation UNIPROT

dbSNP: rs267599092
rs267599092
TTN ; TTN-AS1 ; LOC101927055
0.700 GeneticVariation UNIPROT

dbSNP: rs267600891
rs267600891
RPS6KA2
0.700 GeneticVariation UNIPROT

dbSNP: rs267601046
rs267601046
TTBK1 ; LOC105375064
0.700 GeneticVariation UNIPROT

dbSNP: rs267601191
rs267601191
EPHB4
0.700 GeneticVariation UNIPROT

dbSNP: rs267605306
rs267605306
PKN1
0.700 GeneticVariation UNIPROT

dbSNP: rs369098292
rs369098292
TTN ; TTN-AS1
0.700 GeneticVariation UNIPROT

dbSNP: rs374713701
rs374713701
TTN ; TTN-AS1
0.700 GeneticVariation UNIPROT

dbSNP: rs375422359
rs375422359
TTN ; TTN-AS1
0.700 GeneticVariation UNIPROT

dbSNP: rs55735910
rs55735910
PRKDC
0.700 GeneticVariation UNIPROT

dbSNP: rs564777385
rs564777385
TTN
0.700 GeneticVariation UNIPROT

dbSNP: rs764005465
rs764005465
TTN ; TTN-AS1
0.700 GeneticVariation UNIPROT

dbSNP: rs779173667
rs779173667
PDGFRA
0.700 GeneticVariation UNIPROT

dbSNP: rs868224085
rs868224085
EPHA4
0.700 GeneticVariation UNIPROT

dbSNP: rs907102077
rs907102077
OGG1 ; CAMK1
0.700 GeneticVariation UNIPROT

dbSNP: rs113488022
rs113488022
BRAF
0.100 GeneticVariation BEFREE Currently, several targeted therapy regimens are approved as first-line treatment in V600E/K-mutant advanced and metastatic melanoma. 31305324

2020
dbSNP: rs121913377
rs121913377
BRAF
0.100 GeneticVariation BEFREE Currently, several targeted therapy regimens are approved as first-line treatment in V600E/K-mutant advanced and metastatic melanoma. 31305324

2020
dbSNP: rs113488022
rs113488022
BRAF
0.100 GeneticVariation BEFREE We describe peripheral blood smear, bone marrow morphology, histopathology, immunohistochemistry, including BRAF V600E, and molecular testing results of patients with metastatic melanoma to the bone marrow. 31112348

2019
dbSNP: rs113488022
rs113488022
BRAF
0.100 GeneticVariation BEFREE The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma-Association with Clinical Outcome and Tumor Phenotypes. 31835364

2019
dbSNP: rs113488022
rs113488022
BRAF
0.100 GeneticVariation BEFREE Here, we describe a patient with BRAF-V600E-positive metastatic melanoma who was sequentially treated with BRAF/MEK inhibitors (dabrafenib/trametinib) and checkpoint inhibitor immunotherapy (nivolumab, followed by pembrolizumab). 31082388

2019